GlassScriptPhysician profile
Ruth Stvictor
NPI 1639364896
$1,702.34
in general payments reported to CMS, 2019-2025
30 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $211 · 2021: $244 · 2023: $116 · 2024: $117 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414 · Entertainment: $13.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.85 |
| Entertainment | $13.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $246.65 | 2019-2021 | |
| Coopersurgical, INC. | $199.63 | 2019-2020 | |
| Abbvie INC. | $190.39 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.88 | 2019-2025 | |
| Organon LLC | $108.74 | 2023-2025 | Nexplanon |
| Roche Diagnostics Corporation | $107.44 | 2019-2020 | |
| Biogen, INC. | $78.38 | 2024-2025 | Zurzuvae |
| Avanos Medical | $65.87 | 2019 | |
| Avion Pharmaceuticals | $52.92 | 2020-2023 | Balcoltra |
| Myovant Sciences INC. | $48.17 | 2021 | |
| Daiichi Sankyo INC. | $43.21 | 2019-2020 | |
| Evofem Biosciences, INC. | $41.43 | 2021 | |
| Mayne Pharma Commercial LLC | $41.25 | 2025 | |
| Exeltis, USA INC. | $38.70 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $37.34 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $23.63 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $23.38 | 2019 | |
| Boston Scientific Corporation | $21.82 | 2021 | |
| Medtronic, INC. | $21.33 | 2023 | V-Loc 180 |
| Vertex Pharmaceuticals Incorporated | $19.22 | 2025 | |
| Sumitomo Pharma America, INC. | $18.92 | 2023 | Gemtesa |
| Amag Pharmaceuticals, INC. | $18.86 | 2019 | |
| Exact Sciences Corporation | $18.03 | 2024 | Cologuard Collection Kit |
| Teleflex LLC | $15.72 | 2019 | |
| Allergan, INC. | $15.31 | 2019 | |
| Shield Therapeutics INC | $14.57 | 2024 | |
| Aspira Women'S Health INC | $14.36 | 2024 | Ova1 |
| Dexcom, INC. | $14.15 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $13.79 | 2021 | |
| Argentum Medical | $13.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Stvictor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.